Medication therapy management in the primary care setting: A pharmacist-based pay-for-performance project

Journal of Pharmacy Practice

Volumn 25, Issue 1, 2012, Pages 89-95

  Koenigsfeld, Carrie Foust ^a   Horning, Kristin K ^b,c   Logemann, Craig D ^b,c   Schmidt, Ginelle A ^b,c  

^a Drake Coll of Pharm and Hlth Sci   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c PARTNERS IN HEALTH   (United States)

Author keywords

ambulatory care; incentive reimbursement; medication therapy management; pharmacists

Indexed keywords

ANTIDEPRESSANT AGENT; GENERIC DRUG; HEMOGLOBIN A1C; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; ASTHMA; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; EVALUATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT CARE; PHARMACIST; PRESCRIPTION; PRIMARY MEDICAL CARE;

EID: 84859554920     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190011416671     Document Type: Article

References (22)

1. Centers for Medicare & Medicaid Services - Center for Medicaid and State Operations Value-Based, Results-Driven Healthcare: The Medicaid/CHIP Quality Initiative. July 2006. Accessed at http://www1.cms.gov/ MedicaidCHIPQualPrac/Downloads/qualitystrategy.pdf, October 20, 2010.
2. McGlynn EA, Asch SM, Adams J, et al. The quality of healthcare delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645. http://www.nejm.org/toc/nejm/348/26/. (Pubitemid 36741592)
3. Institute of Medicine. Report: Preventing Medication Errors: Quality Chasm Series. Washington D.C.: Institute of Medicine; July 2006. Accessed at www.nap.edu, October 20, 2010.
4. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192-199.
5. Fenter TC, Lewis SJ. Pay-for-performance initiatives. J Manag Care Pharm. 2008;14(6):S12-S15.
6. Rosenthal MB, Landon BE, Normand ST, et al. Pay for performance in commercial HMOs. N Engl J Med. 2006;355(18):1895-1902. (Pubitemid 44664647)
7. Congressional Research Service. Report for Congress: Pay-for-Performance in Health Care 2006. Accessed at http://www.policyarchive.org/handle/10207/ bitstreams/3009.pdf, October 10, 2010.
8. Nau D. Advancing pharmacy practice through performance measurement: pay for performance. 2009. Accessed at www.cedrugstorenews.com/40199909005H04, October12, 2010.
9. Devine EB, Hoang S, Fisk AW, et al. Strategies to optimize medication use in the physician group practice: the role of the clinical pharmacist. J Am Pharm Assoc. 2009;49:181-191.
10. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med. 1998;158:1641-1647.
11. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy. 2000;20:1508-1516.
12. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy. 2000;20:1198-1203.
13. Yanchick J. Implementation of a pharmacist run drug therapy monitoring clinic in the primary care setting. Am J Health Syst Pharm. 2000;57(suppl 4):S30-S34. (Pubitemid 32005745)
14. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203-211.
15. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40(2):157-165.
16. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-437. (Pubitemid 26115198)
17. Altavela JL, Jones MK, Ritter M. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm. 2008;14(9):831-843.
18. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563-2571. (Pubitemid 44903860)
19. Harris IM, Westberg SM, Frakes MJ, et al. Outcomes of medication therapy review in a family medicine clinic. J Am Pharm Assoc. 2009;49:623-627.
20. Carter BL, Ardery G, Dawson JD, et al. Physician and Pharmacist Collaboration to Improve Blood Pressure Control. Arch Intern Med. 2009;169(21):1996-2002.
21. Johnson JA, Bootman JL. Drug related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm. 1997;54:554-558. (Pubitemid 27114432)
22. The State of Healthcare Quality Report, 2010 by the National Committee for Quality Assurance. Healthcare (NCQA). Accessed at: http://www.ncqa.org/ tabid/172/Default.aspx; October 27, 2010.